Kodak soars another 60% after Trump announces deal to manufacture generic drug ingredients
Source: CNBC
Shares of Kodak soared more than 60% in extended trading. The stock more than tripled during Tuesdays regular trading for its best day ever after the U.S. government awarded the company a $765 million loan to start producing drug ingredients under the Defense Production Act, the first of its kind.
Read more: https://www.cnbc.com/2020/07/28/kodak-soars-another-40percent-after-trump-announces-deal-to-manufacture-generic-drug-ingredients.html
I figured this was coming as a longer term effort to pull critical medical manufacturing back to the US.
But I think it would have been better done through regulation (e.g. make it very expensive to do production overseas) and allow the market to pull back the manufacturing.
dflprincess
(28,094 posts)Maybe toss in a couple flash cubes.
Response to dflprincess (Reply #1)
Chin music This message was self-deleted by its author.
Steelrolled
(2,022 posts)Makes you think all the world's a sunny day, oh yeah
I got a Nikon camera
I love to take a photograph
So mama, don't take my Kodachrome away
dflprincess
(28,094 posts)that eventually came out with a flash extender to hold the flash cube further from the lens because red eye was a major problem with those cameras.
Response to dflprincess (Reply #16)
Chin music This message was self-deleted by its author.
47of74
(18,470 posts)Then I graduated up to 35mm.
progree
(10,939 posts)even better. Just a feeling I have. Just a hunch. Won't know 'til we try.
Come to think of it, injecting ultra-violet light and film-developing chemicals together -- that's one heck of a synergy. That will expose the little Covid bugs.
The company said it will expand existing facilities in Rochester, New York and St. Paul, Minnesota under a new Kodak Pharmaceuticals arm.
Marie Marie
(9,999 posts)Steelrolled
(2,022 posts)From an emotional viewpoint, I would be happy to see a new life for Kodak, although I'm not thrilled about the government taking the risk.
Interesting this development, and the recent executive order linking drug prices in Medicare to lower prices abroad - who's behind it?
TreasonousBastard
(43,049 posts)machI
(1,285 posts)pecosbob
(7,548 posts)chowder66
(9,104 posts)From the article
snip
Eastman Kodak soared on Tuesday after President Donald Trump announced a deal to work with the photography pioneer to produce ingredients in generic drugs in response to the coronavirus pandemic.
Shares of Kodak soared more than 60% in extended trading. The stock more than tripled during Tuesdays regular trading for its best day ever after the U.S. government awarded the company a $765 million loan to start producing drug ingredients under the Defense Production Act, the first of its kind.
snip
Kodak said Tuesday it will produce pharmaceutical components that have been identified as essential but have lapsed into chronic national shortage, as defined by the Food and Drug Administration.
snip
Kodak filed for bankruptcy in 2012 as the shift to digital cameras devastated the business. The move to drug production marks a fighting chance for the onetime leader in film and photography.
pecosbob
(7,548 posts)and not more carpet-bagging.
chowder66
(9,104 posts)and found a little bit on what they might be producing...
A generic drug is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents. Generic drugs are allowed for sale after the patents on the original drugs expire. Because the active chemical substance is the same, the medical profile of generics is believed to be equivalent in performance.[1][2] A generic drug has the same active pharmaceutical ingredient (API) as the original, but it may differ in some characteristics such as the manufacturing process, formulation, excipients, color, taste, and packaging.[2]
https://en.wikipedia.org/wiki/Generic_drug
The terms active constituent or active principle are often chosen when referring to the active substance of interest in a plant (such as salicylic acid in willow bark or arecoline in areca nuts), because the word ingredient in many minds connotes a sense of human agency (that is, something that a person combines with other substances), whereas the natural products present in plants were not added by any human agency but rather occurred naturally ("a plant doesn't have ingredients" .
In contrast with the active ingredients, the inactive ingredients are usually called excipients in pharmaceutical contexts. The main excipient that serves as a medium for conveying the active ingredient is usually called the vehicle. Petrolatum and mineral oil are common vehicles.
https://en.wikipedia.org/wiki/Active_ingredient
I agree with you that the FDA list is bona fide. I'm worried if they get something wrong processing this stuff.
Thekaspervote
(32,820 posts)The idiot buys up all the stock, still has it and instead of releasing it he has the government pay to make more.
No wonder he went bankrupt so many times and is still flat broke
chowder66
(9,104 posts)Hoyt
(54,770 posts)theoretically could help everyone.
Steelrolled
(2,022 posts)the trend of outsourcing everything, especially critical goods such as medical supplies. And the thing we learned recently is that it is "everyone for themselves" when it comes to protecting your medical system in a crisis. Political alliances don't matter.
Demonaut
(8,937 posts)Crazyleftie
(458 posts)follow the money....
this is a big help for ny said cuomo
https://www.governor.ny.gov/news/audio-video-rush-transcript-governor-cuomo-delivers-remarks-launch-765-million-kodak
Paladin
(28,283 posts)ancianita
(36,219 posts)My bet is that Cuomo laid out his publicly announced documentation of harm done to NY through Trump's actual withholding of government supplies and help during NY's COVID peak, and that he'd reconsider if Trump invested in a NY corporation to offset that harm.
Trump knows that SDNY, EDNY and NY AG still have evidence and charges to file, and that those won't go away after Trump leaves office.
Future charges of treason could be in his future, too.